EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

Conditions

Optilume — DEVICE
Has pre-treatment (balloon dilation or ureterotomy) followed by paclitaxel-coated balloon (Optilume) treatment of the ureteric stricture.

The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.

Successful treatment [ Time Frame: 6-months post ureteral stent removal (approximately 7 months post Optilume treatment) ]

Facility	City	State	ZIP	Site coordinators
University of California Irvine	Orange	California	92868	Jaime Landman, MD [email protected] 9498249320 Jaime Landman, MD (PRINCIPAL_INVESTIGATOR)
Orlando Health	Orlando	Florida	32806	Lucas Wiegand, MD [email protected] 877-876-3627 Lucas Wiegand, MD (PRINCIPAL_INVESTIGATOR)
Indiana University	Indianapolis	Indiana	46202	Matthew Mellon, MD [email protected] 317-962-8401
Mount Sinai	New York	New York	10003	Michael Palese, MD [email protected] 212-844-8900 Michael Palese, MD (PRINCIPAL_INVESTIGATOR)
NYU Langone	New York	New York	10016	Lee Zhao, MD [email protected] 646-825-6300
University of Texas Southwestern	Dallas	Texas	75390	Maia VanDyke, MD [email protected] 214-645-8765 Maia VanDyke, MD (PRINCIPAL_INVESTIGATOR)
University of Utah	Salt Lake City	Utah	84112	Benjamin McCormick, MD [email protected] 801-213-2718 Benjamin McCormick, MD (PRINCIPAL_INVESTIGATOR)

By research site